Correlation Between Valneva SE and 50247VAC3
Specify exactly 2 symbols:
By analyzing existing cross correlation between Valneva SE ADR and LYB INTL FIN, you can compare the effects of market volatilities on Valneva SE and 50247VAC3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of 50247VAC3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and 50247VAC3.
Diversification Opportunities for Valneva SE and 50247VAC3
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Valneva and 50247VAC3 is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and LYB INTL FIN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LYB INTL FIN and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with 50247VAC3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LYB INTL FIN has no effect on the direction of Valneva SE i.e., Valneva SE and 50247VAC3 go up and down completely randomly.
Pair Corralation between Valneva SE and 50247VAC3
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the 50247VAC3. In addition to that, Valneva SE is 4.65 times more volatile than LYB INTL FIN. It trades about -0.07 of its total potential returns per unit of risk. LYB INTL FIN is currently generating about -0.1 per unit of volatility. If you would invest 9,096 in LYB INTL FIN on October 10, 2024 and sell it today you would lose (402.00) from holding LYB INTL FIN or give up 4.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 83.61% |
Values | Daily Returns |
Valneva SE ADR vs. LYB INTL FIN
Performance |
Timeline |
Valneva SE ADR |
LYB INTL FIN |
Valneva SE and 50247VAC3 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Valneva SE and 50247VAC3
The main advantage of trading using opposite Valneva SE and 50247VAC3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, 50247VAC3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 50247VAC3 will offset losses from the drop in 50247VAC3's long position.Valneva SE vs. NuCana PLC | Valneva SE vs. Sage Therapeutic | Valneva SE vs. Sellas Life Sciences | Valneva SE vs. Third Harmonic Bio |
50247VAC3 vs. Skechers USA | 50247VAC3 vs. Westinghouse Air Brake | 50247VAC3 vs. Columbia Sportswear | 50247VAC3 vs. Porvair plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamental Analysis View fundamental data based on most recent published financial statements |